Autolus Therapeutics Stock Investor Sentiment
| AUTL Stock | USD 1.63 0.07 4.49% |
About 58% of all Autolus Therapeutics' institutional investors are looking to take a long position. The analysis of the overall investor sentiment regarding Autolus Therapeutics suggests that some traders are interested. Autolus Therapeutics' investing sentiment shows overall attitude of investors towards Autolus Therapeutics.
Comfort Level 58
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Autolus Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Autolus Therapeutics.
News SentimentBullish | Hype SentimentBullish | Insider SentimentWaiting |
Autolus Historical Sentiment
Although Autolus Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Autolus, such as negative comments on social media and news outlets, may cause fear in the market and push Autolus Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Autolus.
Autolus Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Autolus Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Autolus Therapeutics Historical Investor Sentiment
Investor biases related to Autolus Therapeutics' public news can be used to forecast risks associated with an investment in Autolus. The trend in average sentiment can be used to explain how an investor holding Autolus can time the market purely based on public headlines and social activities around Autolus Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Autolus Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Autolus Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Autolus Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Autolus Therapeutics.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Autolus Therapeutics' Stock prices. Below is the latest headlines and news related to Autolus Therapeutics Stock. Current markets are slightly bullish. About 57% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Autolus Therapeutics that are available to investors today. This information is accessible both publicly - through Autolus Therapeutics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Autolus-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Autolus Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Autolus Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Autolus Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Autolus Therapeutics alpha.
Autolus Largest EPS Surprises
Earnings surprises can significantly impact Autolus Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-08 | 2024-06-30 | -0.19 | -0.22 | -0.03 | 15 | ||
2023-08-03 | 2023-06-30 | -0.22 | -0.26 | -0.04 | 18 | ||
2023-05-04 | 2023-03-31 | -0.27 | -0.23 | 0.04 | 14 | ||
2023-03-07 | 2022-12-31 | -0.27 | -0.23 | 0.04 | 14 | ||
2025-08-12 | 2025-06-30 | -0.23 | -0.18 | 0.05 | 21 | ||
2022-03-10 | 2021-12-31 | -0.46 | -0.51 | -0.05 | 10 |
There is far too much social signal, news, headlines, and media speculation about Autolus Therapeutics that are available to investors today. This information is accessible both publicly - through Autolus Therapeutics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Autolus-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Autolus Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Autolus Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Autolus Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Autolus Therapeutics alpha.
Autolus Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Autolus Therapeutics to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025 | 07/24/2025 |
2 | Autolus Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates | 08/12/2025 |
3 | Has Autolus Therapeutics plc Depositary Receipt formed a bullish divergence - Price Action AI Driven Stock Movement Reports - Newser | 08/27/2025 |
4 | Full technical analysis of Autolus Therapeutics plc Depositary Receipt stock - Rate Hike Long-Term Safe Investment Ideas - Newser | 09/04/2025 |
5 | Autolus Therapeutics to Present Clinical Data Update at the American College of Rheumatology Convergence 2025 | 09/16/2025 |
6 | Cerus And 2 Other Promising Penny Stocks To Watch | 09/25/2025 |
Check out Autolus Therapeutics Hype Analysis, Autolus Therapeutics Correlation and Autolus Therapeutics Performance. For more information on how to buy Autolus Stock please use our How to buy in Autolus Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autolus Therapeutics. If investors know Autolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Autolus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.89) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of Autolus Therapeutics is measured differently than its book value, which is the value of Autolus that is recorded on the company's balance sheet. Investors also form their own opinion of Autolus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Autolus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Autolus Therapeutics' market value can be influenced by many factors that don't directly affect Autolus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Autolus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Autolus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Autolus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.